Global Calcium Channel Blocker Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • receipt Report ID : 204232
  • calendar_today Published On: Sep, 2019
  • file_copy Pages: 124
  • list Pharmaceuticals and Healthcare

Calcium channel blockers(CCBs) are medications which are used control high blood pressure, chest pain and arrhythmia. They are available through prescription and work by relaxing blood vessels and increase the blood and oxygen supply to the heart. This reduces the workload of the heart. It can be prescribed by itself or in combination with other medications to treat high blood pressure and angina. There are a few different types of CCB and each works in a slightly different way.

Scope of the Report:

The demand of Calcium Channel Blocker is concentrated in developed areas like USA and Europe. In 2016, the consumption of Calcium Channel Blocker in USA was 26.78%, ahead of other regions. Other regions also enjoy the major market share in global region.

In the future, the Calcium Channel Blocker will have a good future; the price fluctuation has relationship with the raw material. The technology will more mature and the monopoly phenomenon will be weaken. The installed rate in the commercial vehicle will increase.

The worldwide market for Calcium Channel Blocker is expected to grow at a CAGR of roughly 1.5% over the next five years, will reach 78 million US$ in 2024, from 72 million US$ in 2019, according to a new study.

This report focuses on the Calcium Channel Blocker in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

Pfizer

Aventis

Searle

Bayer

AstraZeneca

Knoll Pharmaceuticals

Wyeth-Ayerst

AstraZeneca

Novartis

Sanofi

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Dihydropyridine

Diltiazem

Verapamil

Others

Market Segment by Applications, can be divided into

Hypertension

Coronary Artery Disease

Arrhythmia

Cardiomyopathy

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Calcium Channel Blocker product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Calcium Channel Blocker, with price, sales, revenue and global market share of Calcium Channel Blocker in 2017 and 2018.

Chapter 3, the Calcium Channel Blocker competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Calcium Channel Blocker breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.

Chapter 12, Calcium Channel Blocker market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.

Chapter 13, 14 and 15, to describe Calcium Channel Blocker sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Calcium Channel Blocker Introduction

1.2 Market Analysis by Type

1.2.1 Dihydropyridine

1.2.2 Diltiazem

1.2.3 Verapamil

1.2.4 Others

1.3 Market Analysis by Applications

1.3.1 Hypertension

1.3.2 Coronary Artery Disease

1.3.3 Arrhythmia

1.3.4 Cardiomyopathy

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2014-2024)

1.4.1.2 Canada Market States and Outlook (2014-2024)

1.4.1.3 Mexico Market States and Outlook (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2014-2024)

1.4.2.2 France Market States and Outlook (2014-2024)

1.4.2.3 UK Market States and Outlook (2014-2024)

1.4.2.4 Russia Market States and Outlook (2014-2024)

1.4.2.5 Italy Market States and Outlook (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2014-2024)

1.4.3.2 Japan Market States and Outlook (2014-2024)

1.4.3.3 Korea Market States and Outlook (2014-2024)

1.4.3.4 India Market States and Outlook (2014-2024)

1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2014-2024)

1.4.4.2 Egypt Market States and Outlook (2014-2024)

1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)

1.4.4.4 South Africa Market States and Outlook (2014-2024)

1.4.4.5 Turkey Market States and Outlook (2014-2024)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Pfizer

2.1.1 Business Overview

2.1.2 Calcium Channel Blocker Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Pfizer Calcium Channel Blocker Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.2 Aventis

2.2.1 Business Overview

2.2.2 Calcium Channel Blocker Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Aventis Calcium Channel Blocker Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.3 Searle

2.3.1 Business Overview

2.3.2 Calcium Channel Blocker Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Searle Calcium Channel Blocker Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.4 Bayer

2.4.1 Business Overview

2.4.2 Calcium Channel Blocker Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Bayer Calcium Channel Blocker Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.5 AstraZeneca

2.5.1 Business Overview

2.5.2 Calcium Channel Blocker Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 AstraZeneca Calcium Channel Blocker Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.6 Knoll Pharmaceuticals

2.6.1 Business Overview

2.6.2 Calcium Channel Blocker Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Knoll Pharmaceuticals Calcium Channel Blocker Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.7 Wyeth-Ayerst

2.7.1 Business Overview

2.7.2 Calcium Channel Blocker Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Wyeth-Ayerst Calcium Channel Blocker Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.8 AstraZeneca

2.8.1 Business Overview

2.8.2 Calcium Channel Blocker Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 AstraZeneca Calcium Channel Blocker Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.9 Novartis

2.9.1 Business Overview

2.9.2 Calcium Channel Blocker Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Novartis Calcium Channel Blocker Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.10 Sanofi

2.10.1 Business Overview

2.10.2 Calcium Channel Blocker Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Sanofi Calcium Channel Blocker Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

3 Global Calcium Channel Blocker Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

3.1 Global Calcium Channel Blocker Sales and Market Share by Manufacturer (2017-2018)

3.2 Global Calcium Channel Blocker Revenue and Market Share by Manufacturer (2017-2018)

3.3 Market Concentration Rate

3.3.1 Top 3 Calcium Channel Blocker Manufacturer Market Share in 2018

3.3.2 Top 6 Calcium Channel Blocker Manufacturer Market Share in 2018

3.4 Market Competition Trend

4 Global Calcium Channel Blocker Market Analysis by Regions

4.1 Global Calcium Channel Blocker Sales, Revenue and Market Share by Regions

4.1.1 Global Calcium Channel Blocker Sales and Market Share by Regions (2014-2019)

4.1.2 Global Calcium Channel Blocker Revenue and Market Share by Regions (2014-2019)

4.2 North America Calcium Channel Blocker Sales and Growth Rate (2014-2019)

4.3 Europe Calcium Channel Blocker Sales and Growth Rate (2014-2019)

4.4 Asia-Pacific Calcium Channel Blocker Sales and Growth Rate (2014-2019)

4.5 South America Calcium Channel Blocker Sales and Growth Rate (2014-2019)

4.6 Middle East and Africa Calcium Channel Blocker Sales and Growth Rate (2014-2019)

5 North America Calcium Channel Blocker by Country

5.1 North America Calcium Channel Blocker Sales, Revenue and Market Share by Country

5.1.1 North America Calcium Channel Blocker Sales and Market Share by Country (2014-2019)

5.1.2 North America Calcium Channel Blocker Revenue and Market Share by Country (2014-2019)

5.2 United States Calcium Channel Blocker Sales and Growth Rate (2014-2019)

5.3 Canada Calcium Channel Blocker Sales and Growth Rate (2014-2019)

5.4 Mexico Calcium Channel Blocker Sales and Growth Rate (2014-2019)

6 Europe Calcium Channel Blocker by Country

6.1 Europe Calcium Channel Blocker Sales, Revenue and Market Share by Country

6.1.1 Europe Calcium Channel Blocker Sales and Market Share by Country (2014-2019)

6.1.2 Europe Calcium Channel Blocker Revenue and Market Share by Country (2014-2019)

6.2 Germany Calcium Channel Blocker Sales and Growth Rate (2014-2019)

6.3 UK Calcium Channel Blocker Sales and Growth Rate (2014-2019)

6.4 France Calcium Channel Blocker Sales and Growth Rate (2014-2019)

6.5 Russia Calcium Channel Blocker Sales and Growth Rate (2014-2019)

6.6 Italy Calcium Channel Blocker Sales and Growth Rate (2014-2019)

7 Asia-Pacific Calcium Channel Blocker by Country

7.1 Asia-Pacific Calcium Channel Blocker Sales, Revenue and Market Share by Country

7.1.1 Asia-Pacific Calcium Channel Blocker Sales and Market Share by Country (2014-2019)

7.1.2 Asia-Pacific Calcium Channel Blocker Revenue and Market Share by Country (2014-2019)

7.2 China Calcium Channel Blocker Sales and Growth Rate (2014-2019)

7.3 Japan Calcium Channel Blocker Sales and Growth Rate (2014-2019)

7.4 Korea Calcium Channel Blocker Sales and Growth Rate (2014-2019)

7.5 India Calcium Channel Blocker Sales and Growth Rate (2014-2019)

7.6 Southeast Asia Calcium Channel Blocker Sales and Growth Rate (2014-2019)

8 South America Calcium Channel Blocker by Country

8.1 South America Calcium Channel Blocker Sales, Revenue and Market Share by Country

8.1.1 South America Calcium Channel Blocker Sales and Market Share by Country (2014-2019)

8.1.2 South America Calcium Channel Blocker Revenue and Market Share by Country (2014-2019)

8.2 Brazil Calcium Channel Blocker Sales and Growth Rate (2014-2019)

8.3 Argentina Calcium Channel Blocker Sales and Growth Rate (2014-2019)

8.4 Colombia Calcium Channel Blocker Sales and Growth Rate (2014-2019)

9 Middle East and Africa Calcium Channel Blocker by Countries

9.1 Middle East and Africa Calcium Channel Blocker Sales, Revenue and Market Share by Country

9.1.1 Middle East and Africa Calcium Channel Blocker Sales and Market Share by Country (2014-2019)

9.1.2 Middle East and Africa Calcium Channel Blocker Revenue and Market Share by Country (2014-2019)

9.2 Saudi Arabia Calcium Channel Blocker Sales and Growth Rate (2014-2019)

9.3 Turkey Calcium Channel Blocker Sales and Growth Rate (2014-2019)

9.4 Egypt Calcium Channel Blocker Sales and Growth Rate (2014-2019)

9.5 Nigeria Calcium Channel Blocker Sales and Growth Rate (2014-2019)

9.6 South Africa Calcium Channel Blocker Sales and Growth Rate (2014-2019)

10 Global Calcium Channel Blocker Market Segment by Type

10.1 Global Calcium Channel Blocker Sales, Revenue and Market Share by Type (2014-2019)

10.1.1 Global Calcium Channel Blocker Sales and Market Share by Type (2014-2019)

10.1.2 Global Calcium Channel Blocker Revenue and Market Share by Type (2014-2019)

10.2 Dihydropyridine Sales Growth and Price

10.2.1 Global Dihydropyridine Sales Growth (2014-2019)

10.2.2 Global Dihydropyridine Price (2014-2019)

10.3 Diltiazem Sales Growth and Price

10.3.1 Global Diltiazem Sales Growth (2014-2019)

10.3.2 Global Diltiazem Price (2014-2019)

10.4 Verapamil Sales Growth and Price

10.4.1 Global Verapamil Sales Growth (2014-2019)

10.4.2 Global Verapamil Price (2014-2019)

10.5 Others Sales Growth and Price

10.5.1 Global Others Sales Growth (2014-2019)

10.5.2 Global Others Price (2014-2019)

11 Global Calcium Channel Blocker Market Segment by Application

11.1 Global Calcium Channel Blocker Sales Market Share by Application (2014-2019)

11.2 Hypertension Sales Growth (2014-2019)

11.3 Coronary Artery Disease Sales Growth (2014-2019)

11.4 Arrhythmia Sales Growth (2014-2019)

11.5 Cardiomyopathy Sales Growth (2014-2019)

12 Calcium Channel Blocker Market Forecast (2019-2024)

12.1 Global Calcium Channel Blocker Sales, Revenue and Growth Rate (2019-2024)

12.2 Calcium Channel Blocker Market Forecast by Regions (2019-2024)

12.2.1 North America Calcium Channel Blocker Market Forecast (2019-2024)

12.2.2 Europe Calcium Channel Blocker Market Forecast (2019-2024)

12.2.3 Asia-Pacific Calcium Channel Blocker Market Forecast (2019-2024)

12.2.4 South America Calcium Channel Blocker Market Forecast (2019-2024)

12.2.5 Middle East and Africa Calcium Channel Blocker Market Forecast (2019-2024)

12.3 Calcium Channel Blocker Market Forecast by Type (2019-2024)

12.3.1 Global Calcium Channel Blocker Sales Forecast by Type (2019-2024)

12.3.2 Global Calcium Channel Blocker Market Share Forecast by Type (2019-2024)

12.4 Calcium Channel Blocker Market Forecast by Application (2019-2024)

12.4.1 Global Calcium Channel Blocker Sales Forecast by Application (2019-2024)

12.4.2 Global Calcium Channel Blocker Market Share Forecast by Application (2019-2024)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Calcium Channel Blocker Picture

Table Product Specifications of Calcium Channel Blocker

Figure Global Sales Market Share of Calcium Channel Blocker by Types in 2018<

Please fill the form below, to recieve the report sample


+1